In a groundbreaking transaction, Hill Avenue Cannabis Co., via its parent company, acquired global usage rights to cutting-edge DehydraTECH™ Intellectual Property for infusing CBD and THC into adult use products including edibles, infused beverages, topicals, tinctures, sublingual products, and concentrates. These usage rights were acquired from the Lexaria group of companies in 2020.

Fast-acting patented DehydraTECH™ technology improves the way active pharmaceutical ingredients (APIs) enter the bloodstream, delivering a host of competitive advantages, providing better, faster, more predictable cannabis experiences for consumers. Findings from extensive scientific studies performed by our partner Lexaria include:

Increased bioavailability up to 5-10x to equate to blood absorption by inhalational delivery

Increased brain permeation up to 19x as demonstrated in animal studies

Avoids first-pass liver metabolism mitigating unwanted side effects

Reduced time of onset – effects are felt within 12-20 min vs. 60-120 min

Masks unwanted tastes eliminating the need for sugar-filled edibles

To learn more about DehydraTECH™ visit Lexaria Bioscience Corp.


Introduce the superiority of
DehydraTECH™ to your consumer products
Convert your oil into our superior DehydraTECH™ powder to preserve cannabinoid potency and extend shelf life

Contact Us

Cannabis Technology Inquiry

6 + 10 =